In an era where "wellness" is often reduced to green juices and step counters, the true cornerstone of longevity remains medically rigorous, data-driven preventive care. We usually insure our cars...

The biopharma world is buzzing right now, and one of the biggest stars stealing the spotlight is the bispecific antibody—better known as the BsAb. These molecular multitaskers can latch onto two...

A recent study published in June has rekindled optimism in the oncology field, highlighting a new cancer vaccine that shows significant promise against one of the most lethal malignancies—pancreatic...

As viruses mutate at breakneck speed, traditional antibody therapies are often caught in a game of catch-up. But a recent breakthrough published in Nature Communications (May 2025) might just tip the...

How to scale monoclonal antibody discovery under GMPDuring the event entitled "Generation of a dual-function multi-engager antibody for simultan

Phage Display Library ConstructionCreative Biolabs is excited to play a part as an exhibitor at the upcoming 21st BioPharma Drug Discovery Nexus Conferen

With the U.S. FDA granting emergency use authorization for updated mRNA COVID-19 vaccines on August 22, 2024, the race is on to deliver enhanced protection against the evolving SARS-CoV-2 variants. In...

Creative Biolabs is gearing up to lead the charge in oncolytic virus therapy research.Oncolytic Virus Therapy DevelopmentRecent breakthro

Creative Biolabs is helping to address the demand on the rise for reliable, scalable, and ethically produced antibodies as the biotech industry continues to innovate.

Creative Biolabs attended the 21st BioPharma Drug Discovery Nexus Conference as an exhibitor for the first time on October 22–23.SDAB (Single-Domain Antibodies)"This event, a major hub fo

With the global fight against the monkeypox epidemic intensifying, Creative Biolabs has risen to the occasion by introducing a comprehensive monkeypox virus vaccine development strategy.

Creative Biolabs offers top-notch mRNA technology support to fuel emerging therapeutic discoveries.mRNA technology platformmRNA technology platformRece

Creative Biolabs elaborates on the development mechanisms of DC and mRNA vaccines, two of the most promising cancer vaccine candidates.DC VaccinesThe pursuit

Creative Biolabs introduces its range of TNFRSF9-related antibody reagents.The growing interest in TNFRSF9 (also known as CD137, 4-1BB) stems from its role as a co-stimulatory receptor on T cells...

Recent industry breakthroughs highlight the role of NHPs as a key factor in achieving more accurate preclinical results. Creative Biolabs has responded to this need by expanding its portfolio of NHP...